Company intelligence / Profile preview

AMPO Biotechnology

Ownership: Private
Development stage: Other

Overview

Ampo Biotechnology is a precision medicine company based in Taiwan that specializes in liquid biopsy and circulating tumor cell (CTC) technologies. The company's core platform, i-Quate, utilizes immunomagnetic beads to isolate and enrich CTCs from blood samples with high sensitivity and specificity. This technology enables non-invasive monitoring of cancer progression, treatment response, and the detection of specific biomarkers such as PD-L1 and AR-V7. Ampo Biotechnology provides both automated systems for laboratory use and clinical testing services to support personalized oncology care. Their solutions are designed to assist clinicians in making informed decisions for various solid tumors, including breast, lung, and colorectal cancers.

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on AMPO Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMPO Biotechnology.